← Leaderboards
Maryann E. Mikucki
Roswell Park Cancer Institute Corp
$115,984
Attributed
$115,984
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46K · FY2013–15$50K$37.5K$25K$12.5K$0
'13
'14
'15
Funding mix
By agency
NIH$115,984 · 1
By mechanism
F30$115,984 · 1
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Walter J Storkus$19,974,413
- Pawel Kalinski$15,491,276
- Sharon S Evans$8,115,501
- Scott I. Abrams$11,133,748
- Soldano Ferrone$11,688,743
Others in their field
Top investigators on “Adoptive Cell Transfers”
- Carl H. June · University Of Pennsylvania$34,559,203
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Stanley R Riddell · Fred Hutchinson Cancer Center$24,395,993
- David Artis · Weill Medical Coll Of Cornell Univ$21,071,488
- James L Riley · University Of Pennsylvania$20,821,861
- Antoni Ribas · University Of California Los Angeles$20,752,587
Research focus
Adoptive Cell TransfersAffectApoptosisBaseBinding (Molecular Function)Biological AvailabilityBlocking AntibodiesBloodBlood VesselsCancer ImmunotherapyCancer PatientCancer TherapyCancer TypeCd8b1 GeneCell MotilityCellsCell SurfaceChemokineChemokine ReceptorChemotaxisClinical PracticeCulture MediaCxc Chemokine Receptor 3Adhesives
Grant awards (4)
Chemokine Scavaging as a Mechanism of Tumor Resistance to Immunotherapy$43,094
F30 · FY2015 · CA · contact PI
Chemokine Scavaging as a Mechanism of Tumor Resistance to Immunotherapy$45,989
F30 · FY2014 · CA · contact PI
Chemokine Scavaging as a Mechanism of Tumor Resistance to Immunotherapy$1
F30 · FY2014 · CA · contact PI
Chemokine Scavaging as a Mechanism of Tumor Resistance to Immunotherapy$26,900
F30 · FY2013 · CA · contact PI